Related Experiment Videos
Staphylococcus aureus Tour, a selectively mouse-pathogenic strain for experimental chemotherapeutic study (a note)
Acta Microbiologica Hungarica
|January 1, 1985
Summary
Staphylococcus aureus Tour, a specialized strain, effectively models mouse infections for drug testing. Its high pathogenicity in mice and sensitivity to antibiotics like beta-lactams make it valuable for chemotherapy research.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Staphylococcus aureus Tour is a distinct bacterial strain.
- It exhibits selective pathogenicity, primarily affecting mice.
Purpose of the Study:
- To highlight the utility of S. aureus Tour in preclinical research.
- To demonstrate its suitability for chemotherapeutic studies and infection-protection models.
Main Methods:
- Utilizing S. aureus Tour's selective pathogenicity in mouse models.
- Assessing Minimum Inhibitory Concentrations (MICs) for beta-lactams and gentamicin.
- Determining 50% Effective Doses (ED50s) for cephalosporins in infection-protection studies.
Main Results:
- S. aureus Tour effectively mimics natural infection progression in mice, leading to mortality with low cell counts.
- The strain shows high sensitivity to beta-lactams and gentamicin (low MICs).
- It is effective for evaluating cephalosporins in infection-protection models (low ED50s).
Conclusions:
- S. aureus Tour is a valuable tool for experimental chemotherapeutic studies in mice.
- Its predictable pathogenicity and antibiotic sensitivity facilitate drug efficacy testing.